Stifel Nicolaus began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS - Free Report) in a research note issued to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $28.00 price target on the stock.
Kestra Medical Technologies Stock Performance
Shares of Kestra Medical Technologies stock traded down $1.68 during trading hours on Monday, hitting $24.02. The company's stock had a trading volume of 217,488 shares, compared to its average volume of 285,081. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $26.06.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Further Reading
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
